PROPANC BIOPHARMA, INC. (PPCB) Operating cash flow 2016–2025
PROPANC BIOPHARMA, INC. (PPCB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$405,168FY2025 · since FY2016: -$4.5M → -$405,168
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$405,168 | +56.7% |
| FY2024 | -$935,118 | +15.4% |
| FY2023 | -$1.1M | +23.0% |
| FY2022 | -$1.4M | -25.4% |
| FY2021 | -$1.1M | +38.1% |
| FY2020 | -$1.8M | +10.2% |
| FY2019 | -$2.1M | +5.4% |
| FY2018 | -$2.2M | -6.2% |
| FY2017 | -$2.1M | +54.4% |
| FY2016 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice